BrightBid Group AB (publ) Total Liabilities
BrightBid Group AB (publ) total liabilities. Based on the latest financial reports, BrightBid Group AB (publ) (PERP-B) has total liabilities worth Skr30.44 Million SEK (≈ $3.28 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check PERP-B cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of BrightBid Group AB (publ) (2012–2025)
Total liabilities of BrightBid Group AB (publ) from 2012 to 2025. This chart illustrates how BrightBid Group AB (publ)'s total liabilities have evolved over time, based on quarterly financial data.
BrightBid Group AB (publ) Competitors by Total Liabilities
The table below lists competitors of BrightBid Group AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ModuLink Inc.
NASDAQ:MDLK
|
USA | $775.74K |
|
Tivic Health Systems Inc
NASDAQ:TIVC
|
USA | $27.15 Million |
|
Mercia Technologies PLC
LSE:MERC
|
UK | GBX15.58 Million |
|
Yangaroo Inc
V:YOO
|
Canada | CA$3.79 Million |
|
Lazydays Holdings Inc
NASDAQ:GORV
|
USA | $359.47 Million |
|
Triangle Energy (Global) Ltd
AU:TEG
|
Australia | AU$20.25 Million |
|
Elevai Labs, Inc. Common Stock
NASDAQ:ELAB
|
USA | $19.83 Million |
|
BioSenic S.A.
BR:BIOS
|
Belgium | €28.10 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down BrightBid Group AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is BrightBid Group AB (publ)'s balance sheet.
Liquidity & Leverage Metrics
BrightBid Group AB (publ) Total Liabilities Ratios Explained
BrightBid Group AB (publ) total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.28 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BrightBid Group AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BrightBid Group AB (publ) (2012–2025)
The table below shows the annual total liabilities of BrightBid Group AB (publ) from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr31.44 Million ≈ $3.38 Million |
+299.01% |
| 2024-12-31 | Skr7.88 Million ≈ $847.98K |
+85.89% |
| 2023-12-31 | Skr4.24 Million ≈ $456.18K |
-12.02% |
| 2022-12-31 | Skr4.82 Million ≈ $518.54K |
+1.18% |
| 2021-12-31 | Skr4.76 Million ≈ $512.50K |
+19.25% |
| 2020-12-31 | Skr3.99 Million ≈ $429.77K |
+23.77% |
| 2019-12-31 | Skr3.23 Million ≈ $347.24K |
-22.10% |
| 2018-12-31 | Skr4.14 Million ≈ $445.73K |
+0.48% |
| 2017-12-31 | Skr4.12 Million ≈ $443.58K |
-14.31% |
| 2016-12-31 | Skr4.81 Million ≈ $517.66K |
+146.89% |
| 2015-12-31 | Skr1.95 Million ≈ $209.67K |
+23.21% |
| 2014-12-31 | Skr1.58 Million ≈ $170.17K |
+145.92% |
| 2013-12-31 | Skr643.00K ≈ $69.20K |
-67.19% |
| 2012-12-31 | Skr1.96 Million ≈ $210.93K |
-- |
About BrightBid Group AB (publ)
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. It provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of dr… Read more